BARCLAYS PLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$33
-97.0%
328
-97.0%
0.00%
-100.0%
Q2 2023$1,107
+2159.2%
10,978
+1963.5%
0.00%
Q1 2023$49
-95.6%
532
-95.7%
0.00%
Q4 2022$1,111
-100.0%
12,239
-69.7%
0.00%
-100.0%
Q3 2022$3,065,000
+2204.5%
40,330
+2459.0%
0.00%
Q2 2022$133,000
+269.4%
1,576
+279.8%
0.00%
Q1 2022$36,000
-48.6%
415
-48.8%
0.00%
Q4 2021$70,000
-99.2%
810
-99.2%
0.00%
-100.0%
Q3 2021$8,741,000
+74.5%
106,883
+94.7%
0.00%
+100.0%
Q2 2021$5,008,000
-68.9%
54,889
-70.8%
0.00%
-77.8%
Q1 2021$16,085,000
+48.8%
188,172
+64.4%
0.01%
+50.0%
Q4 2020$10,811,000
-31.0%
114,479
-36.4%
0.01%
-33.3%
Q3 2020$15,657,000
+181.0%
180,041
+182.2%
0.01%
+125.0%
Q2 2020$5,572,000
-63.6%
63,796
-65.6%
0.00%
-69.2%
Q1 2020$15,296,000
-29.0%
185,518
-18.4%
0.01%
+8.3%
Q4 2019$21,534,000
-35.5%
227,419
-40.8%
0.01%
-42.9%
Q3 2019$33,372,000
+172.8%
384,028
+186.7%
0.02%
+162.5%
Q2 2019$12,232,000
+26.7%
133,948
+33.4%
0.01%
+14.3%
Q1 2019$9,653,000
-26.1%
100,394
-34.0%
0.01%
-36.4%
Q4 2018$13,059,000
+173.4%
152,176
+174.5%
0.01%
+175.0%
Q3 2018$4,777,000
-1.6%
55,433
-13.7%
0.00%0.0%
Q2 2018$4,855,000
-41.9%
64,267
-37.8%
0.00%
-42.9%
Q1 2018$8,356,000
+6.9%
103,356
+11.0%
0.01%0.0%
Q4 2017$7,819,000
+97.9%
93,119
+102.3%
0.01%
+75.0%
Q3 2017$3,951,000
+53.6%
46,019
+49.3%
0.00%
+33.3%
Q2 2017$2,573,000
-40.0%
30,819
-46.6%
0.00%
-40.0%
Q1 2017$4,288,000
-22.1%
57,742
-23.6%
0.01%
-28.6%
Q4 2016$5,501,000
-37.1%
75,542
-31.8%
0.01%
-22.2%
Q3 2016$8,741,000
+90.1%
110,685
+98.6%
0.01%
+28.6%
Q2 2016$4,597,000
+9.2%
55,722
-4.7%
0.01%0.0%
Q1 2016$4,208,000
+57.2%
58,442
+87.8%
0.01%
+133.3%
Q4 2015$2,676,000
-59.8%
31,119
-57.5%
0.00%
-62.5%
Q3 2015$6,652,000
-1.2%
73,168
+6.5%
0.01%0.0%
Q2 2015$6,732,000
-33.8%
68,703
-33.8%
0.01%
-33.3%
Q1 2015$10,163,000
+6.8%
103,725
+0.3%
0.01%
+33.3%
Q4 2014$9,516,000
+54.7%
103,454
+58.1%
0.01%
+50.0%
Q3 2014$6,152,000
-18.5%
65,431
-22.0%
0.01%
-14.3%
Q2 2014$7,548,000
-41.1%
83,874
-44.4%
0.01%
-53.3%
Q1 2014$12,825,000
+61.9%
150,852
+52.4%
0.02%
+87.5%
Q4 2013$7,922,000
-14.7%
99,003
-18.9%
0.01%
-27.3%
Q3 2013$9,283,000
+28.9%
122,129
+19.9%
0.01%
+22.2%
Q2 2013$7,200,000101,8400.01%
Other shareholders
NOVARTIS A G shareholders Q1 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders